Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Adding Blood Flow Restriction to Traditional Program After Anterior Cruciate Ligament Reconstruction: A Double-Blinded Randomized Controlled Trial

NCT07406763 is registered in ClinicalTrials.gov with Ahmed Mohamed Mahmoud Abdelaziz Khalil as lead sponsor.

NCT NCT07406763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07406763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Adding Blood Flow Restriction to Traditional Program After Anterior Cruciate Ligament Reconstruction: A Double-Blinded Randomized Controlled Trial
Lead sponsor
Ahmed Mohamed Mahmoud Abdelaziz Khalil
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2020
Completion date
February 1, 2022
Enrollment
36 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anterior cruciate ligament (acl), blood flow restriction therapy